BL PharmTech Corp
KOSDAQ:065170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BL PharmTech Corp
KOSDAQ:065170
|
KR |
|
M
|
Medibank Private Ltd
XMUN:MPV
|
AU |
|
Cash Converters International Ltd
F:UKC
|
AU |
|
B
|
Boundary Gold and Copper Mining Ltd
OTC:PRZFF
|
CA |
|
Doubleview Gold Corp
XTSX:DBG
|
CA |
|
H
|
Hang Lung Group Ltd
XMUN:HLU
|
HK |
|
O
|
O'Reilly Automotive Inc
XMUN:OM6
|
US |
|
Count Ltd
ASX:CUP
|
AU |
|
Carmila SA
F:CUX1
|
FR |
|
O
|
Ocugen Inc
F:2H51
|
US |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
Drax Group PLC
LSE:DRX
|
UK |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
Turners Automotive Group Ltd
NZX:TRA
|
NZ |
|
K
|
Korea Asset Investment Securities Co Ltd
KOSDAQ:190650
|
KR |
|
O
|
Origin Energy Ltd
XMUN:ORL
|
AU |
Intrinsic Value
Is BL PharmTech Corp undervalued or overvalued?
See the intrinsic value estimate for BL PharmTech Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BL PharmTech Corp looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BL PharmTech Corp’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What BL PharmTech Does
BL PharmTech Corp is a South Korean drug maker. It develops, manufactures, and sells pharmaceutical products, including medicines used in hospitals and pharmacies, and it may also produce products for other healthcare companies under contract. Its business is built around making finished drug products rather than selling software or services.
- Headquarters
- Korea KR
- IPO date
- Nov 19, 2002
Revenue & Expenses Breakdown
BL PharmTech Corp
Earnings Waterfall
BL PharmTech Corp
The intrinsic value for BL PharmTech Corp (065170) under the Base Case is hidden KRW.
Compared with the current market price of 1 901 KRW, the stock appears hidden.